[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
what news is relevant
> As far as newspaper
> articles, from the time I first joined radsafe, Sandy Perle has always
> posted a daily review of newspaper articles. Franz, I don't recall
> that you ever criticized him. Are newspaper articles OK, unless Norm
> posts them?
Norm is correct about my posting news, and Norm is also correct in stating that he, and
anyone else, have the right to post any nuclear related news item that is distributed to
the public. Several years ago I was asked in a private E-Mail, that I should not post
unfavorable news items, items that were anti-nuclear. My response then, as it is now, is
that we in the industry need to be cognizant of what is being written about us, around us
and over us. It is only with this knowledge are we able to be better prepared to address,
discuss and promote an adequate response. We are essentially in a war, and, as in all
wars, information is necessary. We need to be aware of the positive, the negative and
the multitude of dis-information that exists. To do otherwise is simply relegating our
industry to be the primary proponent of the "Ostrich Society", where all of its members
can be easily found with their heads in the sand, and their asses up in the air. I don't
think this position is very flattering. Does anyone?
**************************************************************************
Sandy Perle Tel:(714) 545-0100 / (800) 548-5100
Director, Technical Extension 2306
ICN Worldwide Dosimetry Service Fax:(714) 668-3149
ICN Pharmaceuticals, Inc. E-Mail: sandyfl@earthlink.net
ICN Plaza, 3300 Hyland Avenue E-Mail: sperle@icnpharm.com
Costa Mesa, CA 92626
Personal Website: http://sandy-travels.com
ICN Worldwide Dosimetry Website: http://www.dosimetry.com
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line.